Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $368.7500 (-1.86%) ($368.3800 - $379.4500) on Tue. Jul. 12, 2016. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.23% (three month average) | | RSI | 63 | | Latest Price | $368.7500(-1.86%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.5% a day on average for past five trading days. | | Weekly Trend | REGN advances 4.2% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(62%) XLV(50%) XBI(46%) IVW(40%) IWF(40%) | | Factors Impacting REGN price | REGN will decline at least -1.115% in a week (0% probabilities).
VIXM(-9%) UUP(-7%) TLT(-7%) IPO(-6%) IBUY(-4%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.115% (StdDev 2.23%) | | Hourly BBV | 0 () | | Intraday Trend | -2.2% | | | | | |
|
| 5 Day Moving Average | $373.17(-1.18%) | | 10 Day Moving Average | $362.8(1.64%) | | 20 Day Moving Average | $357.93(3.02%) | | To recent high | -12.7% | | To recent low | 11.4% | | Market Cap | $39.098b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |